Regulatory responses to medical machine learning
Journal of Law and the Biosciences · 25.07.2020 · 7 (1)
DOI: 10.1093/jlb/lsaa002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law and the Biosciences, online erschienen am 11.04.2020. Verfasst von Timo Minssen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Advanced Studies in Biomedical Innovation Law, Copenhagen, Denmark. Die Arbeit wurde bisher 93-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Collaborative Research Programme in Biomedical Innovation Law.
Abstract (Originalsprache)
Companies and healthcare providers are developing and implementing new applications of medical artificial intelligence, including the artificial intelligence sub-type of medical machine learning (MML). MML is based on the application of machine learning (ML) algorithms to automatically identify patterns and act on medical data to guide clinical decisions. MML poses challenges and raises important questions, including (1) How will regulators evaluate MML-based medical devices to ensure their safety and effectiveness? and (2) What additional MML considerations should be taken into account in the international context? To address these questions, we analyze the current regulatory approaches to MML in the USA and Europe. We then examine international perspectives and broader implications, discussing considerations such as data privacy, exportation, explanation, training set bias, contextual bias, and trade secrecy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Advanced Studies in Biomedical Innovation Law, Copenhagen, Denmark.
- Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, USA.
- Centre for Law, Medicine, and Life Sciences (LML), Faculty of Law, University of Cambridge, Cambridge, UK.
- University of Michigan Law School, Ann Arbor, MI, USA.
- Harvard Law School and Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Cambridge, USA.
Förderung
- Collaborative Research Programme in Biomedical Innovation Law
Zitieren
APA
Minssen, T., Gerke, S., Aboy, M., Price, N., & Cohen, G. (2020). Regulatory responses to medical machine learning. Journal of Law and the Biosciences, 7(1). https://doi.org/10.1093/jlb/lsaa002
Vancouver
Minssen T, Gerke S, Aboy M, Price N, Cohen G. Regulatory responses to medical machine learning. Journal of Law and the Biosciences. 2020;7(1). doi:10.1093/jlb/lsaa002
BibTeX
@article{Minssen2020,
author = {Minssen, Timo and Gerke, Sara and Aboy, Mateo and Price, Nicholson and Cohen, Glenn},
title = {Regulatory responses to medical machine learning},
journal = {Journal of Law and the Biosciences},
year = {2020},
volume = {7},
number = {1},
doi = {10.1093/jlb/lsaa002}
}
EUVIMED